Evaluation of Myeloid and Lymphoid Regulatory Cell Populations in the Peripheral Blood of Patients Receiving GM-CSF in a Vaccine-Based Immunotherapy Clinical Trial

被引：0
|
作者：
Olson, Walter C. [1 ]
McSkimming, Chantel [1 ]
Slingluff, Craig L. [1 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：872 / 873
页数：2
相关论文
共 50 条
  • [21] Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone
    A Alegre
    JF Tomás
    C Martínez-Chamorro
    JJ Gil-Fernández
    MJ Fernández-Villalta
    R Arranz
    MA Díaz
    A Granda
    MR Bernardo
    A Escudero
    JL López-Lorenzo
    JM Fernández-Rañada
    Bone Marrow Transplantation, 1997, 20 : 211 - 217
  • [22] Post-transplant immunotherapy in patients with multiple myeloma using concurrent lymphoid (IL-2) and antigen-presenting cell (GM-CSF) stimulation.
    Miller, JS
    Vesole, DH
    Burger, S
    Keever-Taylor, CA
    Weisdorf, DJ
    BLOOD, 1999, 94 (10) : 312B - 313B
  • [23] ASSESSMENT OF G-CSF AND GM-CSF MESSENGER-RNA EXPRESSION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA AND IN HUMAN MYELOID LEUKEMIC-CELL LINES
    BERNHARDT, TM
    BURCHARDT, ER
    WELTE, K
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (01) : 163 - 168
  • [24] Posttransplant immunotherapy with a GM-CSF-based tumor vaccine (GVAX®) following autologous stem cell transplant (ASCT) for acute myeloid leukemia (AML).
    Borrello, IM
    Levitsky, HI
    Stock, W
    Scher, D
    Damon, LE
    Linker, CA
    DeAngelo, DJ
    Alyea, EP
    Nelson, L
    Hege, KM
    BLOOD, 2003, 102 (11) : 492A - 492A
  • [25] Posttransplant immunotherapy with a GM-CSF-based tumor vaccine (GVAX®) following autologous stem cell transplant (ASCT) for acute myeloid leukemia (AML)
    DeAngelo, DJ
    Alyea, EP
    Borrello, IM
    Levitsky, HI
    Stock, W
    Sher, D
    Damon, LE
    Linker, CA
    Donnelly, A
    Hege, KM
    BLOOD, 2004, 104 (11) : 129A - 129A
  • [26] Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT)
    Arpaci, F
    Dogru, T
    Ozturk, B
    Komurcu, S
    Ozet, A
    Yilmaz, MI
    Beyzadeoglu, M
    Turan, A
    Sengul, A
    Yalcin, A
    HAEMATOLOGIA, 2002, 32 (03) : 253 - 264
  • [27] Prospective Randomized trial of an allogeneic whole-cell vaccine with or without GM-CSF in resected stage IIB-IV melanoma: Immune and clinical outcomes
    Faries, Mark B.
    Hsueh, Eddy C.
    Essnerr, Richard
    Ye, Xing
    Hoban, Mary
    Morton, Donald L.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 893 - 894
  • [28] PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR BREAST-CANCER PATIENTS WITH BONE-MARROW METASTASES USING GM-CSF PRIMING
    HESTER, JP
    WALLERSTEIN, RO
    TRANSFUSION SCIENCE, 1993, 14 (01): : 65 - 69
  • [29] Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects
    Tate, J
    Olencki, T
    Finke, J
    Kottke-Marchant, K
    Rybicki, LA
    Bukowski, RM
    ANNALS OF ONCOLOGY, 2001, 12 (05) : 655 - 659
  • [30] IgE-independent hypersensitvity reactions are associated with prolonged survival in advanced pancreatic cancer patients receiving a GM-CSF cell-based vaccine plus cyclophosphamide (Cy) and cetuximab.
    Ng, Julie
    Uram, Jennifer
    Onners, Beth
    Biedrzycki, Barbara
    Sugar, Elizabeth
    Solt, Sara
    Armstrong, Todd
    Le, Dung
    Zheng, Lei
    Schroeder, John
    Jaffee, Elizabeth
    Laheru, Daniel
    CANCER RESEARCH, 2013, 73
12345